When it comes to regenerative therapies, the viability of stem cells and exosomes plays a critical role in treatment effectiveness. One of the most common questions patients and providers ask is: How do we ensure these cells remain alive and potent?
In this video, Dr. David Greene, a former Orthopedic Surgeon and CEO of R3 Stem Cell, shares how the company sources, processes, and maintains the high viability of its umbilical cord-derived stem cells and exosomes. He also explains what viability means in the context of cellular therapy and why it matters to your health outcomes.
R3 Stem Cell offers advanced regenerative medicine in seven countries, including the USA, Mexico, Turkey, Philippines, India, Pakistan, and South Africa. Clinics are located in major cities like Phoenix, Los Angeles, New York, Nashville, Miami, San Diego, Delhi, Istanbul, Manila, Johannesburg, and more.
With over 26,000 stem cell procedures performed globally, R3 Stem Cell continues to lead in innovation and patient care.
📞 Schedule your FREE consultation today and discover the power of regenerative medicine.
Comments
Post a Comment